Secondary care management of patients with hidradenitis suppurativa in the United Kingdom and Ireland: a survey of current practice
The results highlight UK disparities in access to HS medical therapies, deroofing and MDT support. Improvements in the standardisation of care are needed. The new National HS MDT run by H-SKIN will help to facilitate this by improving access to specialist support.
Authors
- Hannah E Wainman
- John R Ingram
Institutions
- University Hospitals Bristol NHS Foundation Trust (GB)
- University of Bristol (GB)
- NIHR Bristol Biomedical Research Centre (GB)
- Institute of Infection and Immunity (CA)
- Cardiff University (GB)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1093/ced/llag132
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00